Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Skilarence 120mg gastro-resistant tablets
0802040AKBCABAD
|
Skilarence | Dimethyl fumar | Malignant Disease and Immunosuppression | 10 |
|
Dimethyl fumarate 120mg gastro-resistant tablets
0802040AKAAADAD
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | 8 |
|
Dimethyl fumarate 30mg gastro-resistant tablets
0802040AKAAACAC
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | 6 |
|
Skilarence 30mg gastro-resistant tablets
0802040AKBCAAAC
|
Skilarence | Dimethyl fumar | Malignant Disease and Immunosuppression | 2 |
|
Tecfidera 120mg gastro-resistant capsules
0802040AKBBAAAA
|
Tecfidera | Dimethyl fumar | Malignant Disease and Immunosuppression | 1 |
|
Dimethyl fumarate 120mg gastro-resistant capsules
0802040AKAAAAAA
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | No data available |
|
Dimethyl fumarate 240mg gastro-resistant capsules
0802040AKAAABAB
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | No data available |
|
Tecfidera 240mg gastro-resistant capsules
0802040AKBBABAB
|
Tecfidera | Dimethyl fumar | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.